Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
US stock insider trading | Rhythm disclosed two insider trading transactions on March 6
On March 6, 2026, Rhythm (RYTM) disclosed two insider trading transactions. Executive German Christopher Paul sold 5,614 shares on March 4, 2026.
【Recent Insider Transactions】
【Company Profile】
Rhythm Pharmaceuticals, Inc. is a Delaware corporation founded in February 2013. The company is a global, commercial-stage biopharmaceutical company dedicated to changing the lives of patients and their families affected by rare neuroendocrine diseases. The company focuses on advancing melanocortin-4 receptor agonists, including their lead asset IMCIVREE, as a precision medicine aimed at treating hyperphagia and severe obesity caused by rare MC4R pathway disorders.